Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies
if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the
same subfield and year (this is the minimum needed to enter the top 1%, not the average
within it), or reaches the top citation threshold in at least one of its specific research
topics.
Feasibility, Biodistribution, and Preliminary Dosimetry in Peptide-Targeted Radionuclide Therapy of Diverse Adenocarcinomas Using 177Lu-FAP-2286: First-in-Humans Results
2021210 citationsRichard P. Baum, Christiane Schuchardt et al.Journal of Nuclear Medicineprofile →
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late)
cites ·
hero ref
This map shows the geographic impact of F Robiller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F Robiller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F Robiller more than expected).
This network shows the impact of papers produced by F Robiller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F Robiller. The network helps show where F Robiller may publish in the future.
Co-authorship network of co-authors of F Robiller
This figure shows the co-authorship network connecting the top 25 collaborators of F Robiller.
A scholar is included among the top collaborators of F Robiller based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with F Robiller. F Robiller is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
Baum, Richard P., Christiane Schuchardt, Aviral Singh, et al.. (2021). Feasibility, Biodistribution, and Preliminary Dosimetry in Peptide-Targeted Radionuclide Therapy of Diverse Adenocarcinomas Using 177Lu-FAP-2286: First-in-Humans Results. Journal of Nuclear Medicine. 63(3). 415–423.210 indexed citations breakdown →
Robiller, F, et al.. (1975). The budgerigar (Melopsittacus undulatus) as endocrinological test model. Thyroxine transport in blood.. PubMed. 64(3). 329–32.3 indexed citations
8.
Robiller, F. (1974). [The fate with time of protein-bound 131-iodine in the budgerigar (Melopsittacus undulatus) with simultaneous measurement of activity in the liver and other organs].. PubMed. 28(1). 7–10.1 indexed citations
9.
Robiller, F, et al.. (1972). [Comparison of function and morphology of the thyroid gland of the budgerigar (Melopsittacus undulatus)].. PubMed. 132(3). 401–9.1 indexed citations
10.
Robiller, F, et al.. (1972). Autoradiographic studies on iodine distribution in the thyroid gland of the budgerigar (Melopsittacus undulatus).. PubMed. 7(5). 345–6.1 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.